Here, this study mined the transcription factor USF1 of HAS2-AS1 through bioinformatics, and explored the influence of HAS2-AS1 on the invasion and migration of glioma cells, which provided a new theoretical basis for the targeted treatment of glioma. This evidence concerns the gene HAS2 and central nervous system cancer.